Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Indian Journal of Gastroenterology
Published in: Indian Journal of Gastroenterology 3/2011

01-05-2011 | Review Article

Questionnaire based gastroesophageal reflux disease (GERD) assessment scales

Authors: V. Pratap Mouli, Vineet Ahuja

Published in: Indian Journal of Gastroenterology | Issue 3/2011

Login to get access

Abstract

Questionnaire based assessment scales for gastroesophageal reflux disease (GERD) have been utilized for assessment of the patient’s symptomatology, assessment of symptom severity and frequency, assessment of health-related quality of life and for assessment of response to treatment. A multitude of unidimensional and multidimensional questionnaires exist for making symptom assessment and monitoring quality of life in GERD. Many of the scales meet some of the parameters of an ideal evaluative GERD specific assessment instrument. Yet, there are certain shortcomings and challenges which are faced in development of GERD questionnaires. This review discusses the features of an ideal symptom assessment instrument, examines the strengths and weaknesses of currently available questionnaires.
Literature
1.
Holtmann G. Reflux disease: the disorder of the third millennium. Eur J Gastroenterol Hepatol. 2001;13 suppl 1:S5–11.PubMed
2.
Sharma PK, Ahuja V, Madan K, et al. Prevalence, severity, and risk factors of symptomatic gastroesophageal reflux disease among employees of a large hospital in Northern India. Indian J Gastroenterol. 2010; Nov 9. [Epub ahead of print].
3.
Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20. quiz 1943.PubMedCrossRef
4.
Wu WC. Ancillary tests in the diagnosis of gastroesophageal reflux disease. Gastroenterol Clin North Am. 1990;19:671–82.PubMed
5.
Klauser AG, Schindlbeck NE, Müller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335:205–8.PubMedCrossRef
6.
Kaul B, Halvorsen T, Petersen H, et al. Gastrooesophageal reflux disease. Scintigraphic, endoscopic, and histologic considerations. Scand J Gastroenterol. 1986;21:134–8.PubMedCrossRef
7.
McDonald JWD, Burroughs AK, Feagan BG, Fennetry MB. Evidence-Based Gastroenterology and Hepatology, 3rd ed. UK:John Wiley and Sons Ltd; Sep 2010. p. 25.
8.
Madan K, Ahuja V, Dutta Gupta S, et al. Impact of 24-hr oesophageal pH monitoring on the diagnosis of gastroesophageal reflux disease: defining the gold standard. J Gastroenterol Hepatol. 2005;20:30–7.PubMedCrossRef
9.
Greatorex R, Thorpe JA. Clinical assessment of gastroesophageal reflux by questionnaire. Br J Clin Pract. 1983;37:133–5.PubMed
10.
Mold JW, Reed LE, Davis AB, et al. Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol. 1991;8:965–70.
11.
Raiha IJ, Impivaara O, Seppala M, et al. Prevalence and characteristics of symptomatic gastroesophageal reflux disease in the elderly. J Am Geriatr Soc. 1992;40:1209–11.PubMed
12.
Johnsson F, Roth Y, Damgaard Pedersen NE, et al. Cimetidine improves GERD symptoms in patients selected by a validated GERD questionnaire. Aliment Pharmacol Ther. 1993;7:81–6.PubMedCrossRef
13.
Orenstein SR, Cohn JF, Shalaby TM, et al. Reliability and validity of an infant gastroesophageal reflux questionnaire. Clin Pediatr (Phila). 1993;32:472–84.CrossRef
14.
Locke GR, Talley NJ, Weaver AL, et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 1994;69:539–47.PubMed
15.
Williford WO, Krol WF, Spechler SJ. Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial. VA Cooperative Study Group on Gastroesophageal Reflux Disease (GERD). Control Clin Trials. 1994;15:335–48.PubMedCrossRef
16.
Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33:1023–9.PubMedCrossRef
17.
Manterola C, Munoz S, Grande L, et al. Construction and validation of a gastroesophageal reflux symptom scale. Preliminary report. Rev Med Chil. 1999;127:1213–22.PubMed
18.
Allen CJ, Parameswaran K, Belda J, et al. Reproducibility, validity, and responsiveness of a disease-specific symptom questionnaire for gastrooesophageal reflux disease. Dis Oesophagus. 2000;13:265–70.CrossRef
19.
Rothman M, Farup C, Stewart W, et al. Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials. Dig Dis Sci. 2001;46:1540–9.PubMedCrossRef
20.
Ofman JJ, Shaw M, Sadik K, et al. Identifying patients with gastroesophageal reflux disease. Dig Dis Sci. 2002;47:1863–9.PubMedCrossRef
21.
Vigneri S, Termini R, Leandro G, et al. A comparision of five maintenance therapies for reflux oesophagitis. N Engl J Med. 1995;333:1106–10.PubMedCrossRef
22.
Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol. 2001;96:52–7.PubMedCrossRef
23.
Wong WM, Lam KF, Lai KC, et al. A validated symptoms questionnaire (Chinese GERDQ) for the diagnosis of gastro-oesophageal reflux disease in the Chinese population. Aliment Pharmacol Ther. 2003;17:1407–13.PubMedCrossRef
24.
Reidel WL, Clouse RE. Variations in clinical presentation of patients with oesophageal contraction abnormalities. Dig Dis Sci. 1985;30:1065–71.PubMedCrossRef
25.
Andersen LI, Madsen PV, Dalgaard P, et al. Validity of clinical symptoms in benign oesophageal disease, assessed by questionnaire. Acta Med Scand. 1987;221:171–7.PubMedCrossRef
26.
Revicki DA, Wood M, Wiklund I, et al. Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease. Qual Life Res. 1998;7:75–83.PubMedCrossRef
27.
Ruth M, Mansson I, Sandberg N. The prevalence of symptoms suggestive of oesophageal disorders. Scand J Gastroenterol. 1991;26:73–81.PubMedCrossRef
28.
Dimenäs E, Glise H, Hallerback B, et al. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol. 1993;28:681–7.PubMedCrossRef
29.
Shaw M, Talley NJ, Adlis S, et al. Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population. Aliment Pharmacol Ther. 1998;12:1067–78.PubMedCrossRef
30.
Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol. 1998;93:1816–22.PubMedCrossRef
31.
Velanovich V, Vallance SR, Gusz JR, et al. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg. 1996;183:217–24.PubMed
32.
Young TL, Kirchdoerfer LJ, Osterhaus JT. A development and validation process for a disease-specific quality of life instrument. Drug Inf J. 1996;30:185–93.
33.
Jasani K, Piterman L, McCall L. Gastrooesophageal reflux and quality of life. Patient’s knowledge, attitudes and perceptions. Aust Fam Physician. 1999;28 Suppl 1:S15–8.PubMed
34.
Raymond JM, Marquis P, Bechade D, et al. Assessment of quality of life of patients with gastroesophageal reflux. Elaboration and validation of a specific questionnaire. Gastroenterol Clin Biol. 1999;23:32–9.PubMed
35.
Amouretti M, Nalet B, Robaszkiewicz M, et al. Validation of the short-form REFLUX-QUAL (RQS), a gastro-oesophageal reflux disease (GERD) specific quality of life questionnaire. Gastroenterol Clin Biol. 2005;29:793–801.PubMedCrossRef
36.
Wahlqvist P, Carlsson J, Stalhammar NO, et al. Validity of a work productivity and activity impairment questionnaire for patients with symptoms of gastro-oesophageal reflux disease (WPAI-GERD) — results from a cross-sectional study. Value Health. 2002;5:106–13.PubMedCrossRef
37.
Zeman Z, Rozsa S, Tihanyi T, et al. Psychometric documentation of a quality-of-life questionnaire for patients undergoing antireflux surgery (QOLARS). Surg Endosc. 2005;19:257–61.PubMedCrossRef
38.
Chan Y, Ching JYL, Cheung MY, et al. Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease: the GERD-QOL questionnaire. Aliment Pharmacol Ther. 2010;31:452–60. Epub 2009 Oct 31.PubMedCrossRef
39.
Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal quality of life index: development validation and application of a new instrument. Br J Surg. 1995;82:216–22.PubMedCrossRef
40.
Wiklund IK, Junghard O, Grace E, et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl. 1998;583:41–9.PubMed
41.
De la Loge C, Trudeau E, Marquis P, et al. Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res. 2004;13:1751–62.PubMedCrossRef
42.
Dupuy HJ. The Psychological General Well-Being (PGWB) Index. In: Wender NK, Mattson ME, Furberg CD, et al., eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York: Le Jacq; 1984. p. 170–83.
43.
Group EuroQol. EuroQol - a new facility for measurement of health related quality of life. Health Policy. 1990;16:199–208.CrossRef
44.
McHorney CA, Ware Jr JE, Lu JF, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32:40–66.PubMedCrossRef
45.
Colwell HH, Mathias SD, Pasta DJ, et al. Development of a health-related quality-of-life questionnaire for individuals with gastroesophageal reflux disease: a validation study. Dig Dis Sci. 1999;44:1376–83.PubMedCrossRef
46.
Mathias SD, Castell DO, Elkin EP, et al. Health-related quality of life of patients with acute erosive reflux oesophagitis. Dig Dis Sci. 1996;41:2123–9.PubMedCrossRef
47.
Mathias SD, Colwell HH, Miller DP, et al. Health-related quality-of-life and quality-days incrementally gained in symptomatic nonerosive GERD patients treated with lansoprazole or ranitidine. Dig Dis Sci. 2001;46:2416–23.PubMedCrossRef
48.
Eggleston A, Farup C, Meier R. The domestic/international gastroenterology surveillance study (DIGEST): design, subjects. All patients referred over a one-year period for clinical oesophageal manometry were asked to carefully characterize their oesophageal symptoms on a self-report questionnaire and methods. Scand J Gastroenterol Suppl. 1999;231:9–14.PubMed
49.
Bardhan KD, Stanghellini V, Armstrong D, et al. Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest TM. Digestion. 2004;69:229–37.PubMedCrossRef
50.
Spiegel BM, Roberts L, Mody R, et al. The development and validation of a nocturnal gastro-oesophageal reflux disease symptom severity and impact questionnaire for adults. Aliment Pharmacol Ther. 2010;32:591–602. Epub 2010 Jun 2.PubMedCrossRef
51.
Shaw MJ, Beebe TJ, Adlis SA, et al. Reliablity and validity of the digestive health status instrument in samples of community, primary care, and gastroenterology patients. Aliment Pharmacol Ther. 2001;15:981–7.PubMedCrossRef
52.
Moreno Elola-Olaso C, Rey E, Rodríguez-Artalejo F, et al. Adaptation and validation of a gastrooesophageal reflux questionnaire for use on a Spanish population. Rev Esp Enferm Dig. 2002;94:745–58.PubMed
53.
Manterola C, Munoz S, Grande L, et al. Initial validation of a questionnaire for detecting gastrooesophageal reflux disease in epidemiological settings. J Clin Epidemiol. 2002;55:1041–5.PubMedCrossRef
54.
Madan K, Ahuja V, Sharma MP, et al. Comparision of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesphageal reflux disease: a randomized trial. Dis Oesophagus. 2004;17:274–8.CrossRef
55.
Kumar S, Ahuja V, Saraya A, et al. Population based study to assess prevalence and risk factors of gastroesophageal reflux disease in a high altitude area. Indian J Gastroenterol 2011;30:doi:10.​1007/​s12664-010-0065-5.
56.
Talley NJ, Phillips SF, Melton LJ, et al. A patient questionnaire to identify bowel disease. Ann Intern Med. 1989;11:671–4.
57.
Nocon M, Kulig M, Leodolter A, et al. Validation of the reflux disease questionnaire for a German population. Eur J Gastroenterol Hepatol. 2005;17:229–33.PubMedCrossRef
58.
Shaw M, Dent J, Beebe T, et al. The reflux disease questionnaire: a measure for assessment of treatment response in clinical trials. Health Qual Life Outcomes. 2008;6:31.PubMedCrossRef
59.
Svedlund J, Sjodin I, Dovetall G. GSRS-a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33:129–34.PubMedCrossRef
60.
Talley N, Fullerton S, Junghard O, et al. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol. 2001;96:1998–2004.PubMedCrossRef
61.
Stanghellini V, Armstrong D, Monnikes H, et al. Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire? Aliment Pharmacol Ther. 2004;19:463–79.PubMedCrossRef
62.
Velanovich V. Comparison of generic (SF-36) vs. disease-specific (GERD-HRQL) quality-of-life scales for gasro-oesophageal reflux disease. J Gastrointest Surg. 1998;2:141–5.PubMedCrossRef
63.
Rush DR, Stelmach WJ, Young TL, et al. Clinical effectiveness and quality of life with ranitidine vs placebo in gastro-oesophageal reflux disease patients: a clinical experience network (CEN) study. J Fam Pract. 1995;41:126–36.PubMed
64.
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treament of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.PubMedCrossRef
65.
Visick AH. A study of the failures after gastrectomy. Ann R Coll Surg Engl. 1948;3:184–226.
66.
Kleinman L, Leidy NK, Crawley J, et al. A comparative trial of paper-and-pencil vs. computer administration of the quality of life in reflux and dyspepsia (QOLRAD) questionnaire. Med Care. 2001;39:181–9.PubMedCrossRef
67.
Naughton MJ, Wiklund I. A critical review of dimension-specific measures of health-related quality of life in cross-cultural research. Qual Life Res. 1993;2:397–432.
68.
McHorney CA, Ware JE, Lu JFR, et al. The MOS 36-Item Short-Form Health Survey (SF-36): III. tests of data quality, scaling assumptions and reliability across diverse patient groups. Med Care. 1994;32:40–66.PubMedCrossRef
69.
Korolija D, Sauerland S, Wood-Dauphinee S, et al. European Association for Endoscopic Surgery. Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European Association for Endoscopic Surgery. Surg Endosc. 2004;18:879–97.PubMedCrossRef
70.
Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.PubMedCrossRef
71.
Fraser A, Delaney B, Moayyedi P. Symptom-based outcome measures for dyspepsia and GERD trials: a systematic review. Am J Gastroenterol. 2005;100:442–52.PubMedCrossRef
72.
Bardhan K, Armstrong D, Fass R, et al. The ReQuestt/LA-classification: a novel integrated approach for the comprehensive assessment of treatment outcome of gastrooesophageal reflux disease (GERD). Can J Gastroenterol. 2005;19 suppl C:R.0031.
73.
Stanghellini V, Armstrong D, Monnikes H, et al. Determination of ReQuest based symptom thresholds to define symptom relief in GERD clinical studies. Digestion. 2005;71:145–51.PubMedCrossRef
74.
López LH, Schneider OP, Vargas AJ, et al. Effectiveness of pantoprazole magnesium dihydrate in the treatment of symptoms in gastroesophageal reflux disease. Gut. 2006;55 Suppl V:A275.
75.
Mönnikes H, Bardhan KD, Stanghellini V, et al. Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuestTM in erosive GERD. Digestion. 2004;69:238–44.PubMedCrossRef
76.
Bardhan KD, Stanghellini V, Armstrong D, et al. International validation of ReQuestTM in patients with endoscopy-negative gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2004;20:891–8.PubMedCrossRef
77.
Metadata
Title
Questionnaire based gastroesophageal reflux disease (GERD) assessment scales
Authors
V. Pratap Mouli
Vineet Ahuja
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Indian Journal of Gastroenterology / Issue 3/2011
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-011-0105-9

Other articles of this Issue 3/2011

Indian Journal of Gastroenterology 3/2011 Go to the issue

Original Article

Prevalence and risk factors for gastroesophageal reflux in pregnancy

Editorial

Shedding light on the epidemiology of gastroesophageal reflux disease in India—a big step forward

Original Article

Prevalence, severity, and risk factors of symptomatic gastroesophageal reflux disease among employees of a large hospital in Northern India

Preamble

Gastroesophageal reflux disease in India: ISG Task Force completes a task!

Original Article

Population based study to assess prevalence and risk factors of gastroesophageal reflux disease in a high altitude area

ISG Task Force Report

Epidemiology and symptom profile of gastroesophageal reflux in the Indian population: Report of the Indian Society of Gastroenterology Task Force
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits